Search clinical trials for: Drug: 68Ga-P16-093

Total 2881 results

National Institute of Neurological Disorders and...

Completed

Treatment of Parkinson's Disease With a Transdermal Skin Patch

Parkinson Disease

United States
Takeda

Recruiting

A Study of Dengue Vaccine in Healthy Children, Teenagers and Adults in India

Healthy Volunteers

India
AbbVie

Completed

A Study to Assess the Mass Balance of [14C] ABBV-903 in Healthy Male Participants Following Single Oral Dose Administration

Healthy Volunteer

United States
Beckley Psytech Limited

Completed

Single Ascending Dose Study With BPL-003 in Healthy Subjects

Pharmacokinetics in Healthy Adults

United Kingdom
Memorial Sloan Kettering Cancer Center

Recruiting

A Study of 68Ga-PSMA-11 PET Scans in People With Brain Tumors

Brain Metastases | Brain Metastases, Adult | High-grade Glioma

United States
Centre de recherche du Centre hospitalier universitaire...

Recruiting

68Ga-PSMA PET Imaging of Upper Metastatic Gastric Cancers to Determine Eligibility to Endoradiotherapy (ERD2021)

Upper Digestive Tract Cancer

Canada
Universitaire Ziekenhuizen KU Leuven

Recruiting

High Precision Imaging of Prostate Specific Membrane Antigen for Personalized Treatment in Prostate Cancer

Prostate Cancer

Belgium
Clinton Bahler

Completed

The Role of 68Ga-PSMA-11 PET (Prostate Specific Membrane Antigen) in Surgery Guidance in Prostate Cancer

Prostate Cancer

United States
University of Washington

Recruiting

An Investigational Scan (68Ga-PSMA-11 PET) for the Imaging of Prostate Cancer

Biochemically Recurrent Prostate Carcinoma | Castration-Resistant Prostate Carcinoma | Prostate Adenocarcinoma | Stage IV Prostate Cancer AJCC v8

United States
AbbVie

Completed

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-493 and ABT-530 With and Without Ribavirin in Adults With HCV Who Failed a Prior DAA Containing Therapy

Chronic Hepatitis C | Hepatitis C Virus | HCV | Direct-Acting Antiviral Agent (DAA)-Experienced
Chong Kun Dang Pharmaceutical
Asan Medical Center

Unknown

A Phase 1/2a Study to Assess the Safety and Efficacy of CKD-516 Tab. in Combination With Irinotecan Inj.

Colorectal Cancer

Korea, Republic of
University of California, San Francisco

Terminated

Gallium-68 Prostate Specific Membrane Antigen PET in Diagnosing Patients With Thyroid Cancer

Thyroid Gland Carcinoma

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Withdrawn

Gallium-68 PSMA-11 PET in Participants With Prostate Cancer

Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Recurrent Prostate Carcinoma | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8
Double Bond Pharmaceutical AB

Not yet recruiting

A Dose Escalation Study to Estimate MTD, DLTs and Pharmacokinetics After a Single Intracranial Dose of SI-053 as an add-on to the Current Standard of Care, in Adult Patients With Newly Diagnosed GBM (TARGLIO)

Newly Diagnosed Glioblastoma
Rhythm Pharmaceuticals, Inc.

Completed

Setmelanotide for the Treatment of Early-Onset Pro-Opiomelanocortin (POMC) Deficiency Obesity

Pro-opiomelanocortin (POMC) Deficiency Obesity

Belgium, United States, Canada, France, Germany, Spain, United Kingdom
Takeda

Completed

Lot-to-lot Consistency of 3 Lots of Tetravalent Dengue Vaccine (TDV) in Non-endemic Country(Ies) for Dengue

Dengue Fever

United States
Istituto Scientifico Romagnolo per lo Studio e...

Recruiting

Mp-3TMRI and 68Ga-PSMA PET/CT Guided Prostate Biopsy and Tumor Node Metastasis (TNM) Staging. (BIOPSTAGE)

Prostate Cancer | Diagnosis | 68Ga-PSMA PET/CT Guided Prostate Biopsy | Mp-3TMRI Guided Prostate Biopsy | TNM Staging

Italy
Shadia Jalal, MD
GlaxoSmithKline; Indiana University School of Medicine

Terminated

A Study Evaluating Safety and Efficacy of Niraparib in Patients With Previously Treated Metastatic Esophageal/Gastroesophageal Junction/Proximal Gastric Adenocarcinoma

Adenocarcinoma | Gastric Cancer | Esophageal Cancer

United States
Novartis Pharmaceuticals

Completed

Study of Diagnostic Performance of [18F]CTT1057 in BCR (GuidePath)

Recurrence | Prostatic Neoplasms | Prostate Cancer

Spain, France, Switzerland, United States
Turku University Hospital
University of Turku

Unknown

PET-imaging of Unruptured Intracranial Aneurysm Inflammation (PET-IA)

Inflammation | Cerebral Aneurysm | Intracranial Aneurysm

Finland
Daewoong Pharmaceutical Co. LTD.

Not yet recruiting

Study to Evaluate the Long Term Safety and Efficacy of DWP16001 in Patients With Type 2 Diabetes Mellitus

T2DM (Type 2 Diabetes Mellitus)
Acceleron Pharma Inc. (a wholly owned subsidiary...

Terminated

Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease

Charcot-Marie-Tooth Disease

United States
Pfizer

Completed

A Study to Assess the Safety and Tolerability of Different Doses of PF-05402536 and PF-06413367 in Healthy Adult Smokers.

Smoking | Vaccines

Canada
Peking Union Medical College Hospital

Recruiting

68Ga-DOTA-F2 PET/CT in Patients With Various Types of Cancer

Tumor, Solid

China
Thomas Hope
Clovis Oncology, Inc.

Recruiting

Imaging of Pathologic Fibrosis Using 68Ga-FAP-2286

Myocardial Fibrosis | Pulmonary Fibrosis | Liver Fibrosis

United States
The Methodist Hospital Research Institute

Completed

68 Ga-PSMA for High Risk Prostate Cancer

Prostate Cancer | High Risk

United States
Ajit H. Goenka, MD

Completed

68 Ga PSMA PET/MRI for Hepatocellular Carcinoma

Hepatocellular Carcinoma

United States
Argos Therapeutics

Terminated

A Rollover Protocol for Subjects Previously Treated With AGS-003

Renal Cell Carcinoma

United States
Rhythm Pharmaceuticals, Inc.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Effects of RM-493 on Energy Expenditure in Obese Individuals

Obesity | Morbid Obesity

United States
Dupont Applied Biosciences

Unknown

Safety and Effectiveness of the Drug DPC 083 in Combination With Nucleoside Analogue Reverse Transcriptase Inhibitors in HIV-1-Infected Patients Who Are Failing Treatment With Nonnucleoside Reverse Transcriptase Inhibitors

HIV Infections

United States
GenMont Biotech Incorporation
National Science Council, Taiwan

Completed

Probiotics and Allergic Diseases (probiotics)

Asthma | Atopic Dermatitis

Taiwan
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Terminated

Vaccine Therapy Before Surgery in Treating Patients With Localized Kidney Cancer

Recurrent Renal Cell Carcinoma | Stage I Renal Cell Cancer | Stage II Renal Cell Cancer

United States
Azienda Ospedaliero-Universitaria di Modena

Recruiting

Evaluation of Diagnostic Accuracy of [68Ga]Ga-PSMA-11 PET/CT in Primary Staging of Intermediate and High Risk Prostatic Cancer in Men Newly Diagnosed (PSMA-PROSTAPET)

Neoplasms | Urogenital Neoplasms | Disease Attributes | Prostate Cancer | Prostatic Neoplasm | Prostatic Disease

Italy
The First Affiliated Hospital of Xiamen University

Recruiting

Comparison of FDG and FAPI in Patients With Various Types of Cancer

Metastasis | Positron-Emission Tomography | Tumor, Solid

China
West Virginia University

Recruiting

A Comparison of NETSPOT Imaging Versus F-FDG-PET in Head and Neck Cancer Patients

Head and Neck Squamous Cell Carcinoma

United States
Medical University of Vienna
BSM Diagnostica GmbH Vienna; Siemens Healthcare GmbH

Completed

PET/MRI in Patients With Suspected Prostate Cancer

Prostate Cancer

Austria
National University Hospital, Singapore
Tan Tock Seng Hospital

Unknown

Evaluation of Somatostatin Receptor Imaging Using PET/MRI as a Novel Approach to Detecting Pathology in Pulmonary TB

Tuberculosis

Singapore
Memorial Sloan Kettering Cancer Center

No longer available

68Ga-DOTATOC for Imaging of Neuroendocrine Tumors: Expanded Access Trial

Neuroendocrine Tumors

United States
Stanford University

Not yet recruiting

68-Ga-FAPI PET Imaging in Malignancy

Cancer

United States
Insel Gruppe AG, University Hospital Bern

Active, not recruiting

Head-to-head Comparison of 68Ga-PSMA-11 and 18F-PSMA-1007

Prostate Cancer

Switzerland
The First Affiliated Hospital of Xiamen University

Completed

68Ga-FAPI-RGD PET/CT for Dual Integrin αvβ3 and FAP-targeted Imaging in Patients With Various Types of Cancer and Compared With 18F-FDG

Positron-Emission Tomography | Tumor, Solid

China
Central Hospital, Nancy, France
GIE NANCYCLOTEP; Advanced Nuclear Medicine Ingredients (ANMI)

Unknown

Comparison of PET With 68GA-PSMA-11 and 18F-Fluorocholine for Recurrence in Men With Prostate Cancer (TEPGALCHOL)

Prostate Cancer

France
University of Copenhagen
Science, Toxicology & Technology, San Francisco, California

Completed

B181: Stimulation of Thermogenesis by Bio-Active Food Ingredients

Obesity

Denmark
Mayo Clinic

Not yet recruiting

An Investigational Scan (Ga-68 PSMA-11 PET/CT) for Detection of Disease Recurrence or Progression in Patients With Glioma

WHO Grade 3 Glioma | WHO Grade 2 Glioma | WHO Grade 4 Glioma

United States
Mayo Clinic
National Cancer Institute (NCI); United States Department of Defense

Recruiting

68Ga-PSMA-Dual-Contrast PET/MRI or PET/CT for Early Detection of Liver Cancer

Hepatocellular Carcinoma

United States
Vertex Pharmaceuticals Incorporated

Recruiting

A Phase 1 Dose Escalation Study of Intravenous VX-993 in Healthy Adults

Pain

United States
The First Affiliated Hospital of Xiamen University

Recruiting

68Ga-FAPI-LM3 PET/CT Imaging in Patients With FAP/SSTR2 Positive Disease and Compared With 18F-FDG

Positron-Emission Tomography | FAP | SSTR2

China
Medical University of Bialystok
Medical Research Agency, Poland

Recruiting

Multicenter Assessment of Clinical Utility PET / MR With the Use of the Radiotracer 68Ga-PSMA-11 in Therapy Planning Personalized in Patients With Prostate Cancer (PROSPETMR2021)

Prostate Cancer

Poland
Weill Medical College of Cornell University

Completed

PSMA Imaging of Localized Prostate Cancer

Prostate Cancer

United States
Peking Union Medical College Hospital

Unknown

18F-FDG and 68Ga-FAPI PET/CT in Crohn's Disease

Crohn Disease

Search clinical trials for: Drug: 68Ga-P16-093

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations